Peregrine Capital Management LLC Avid Bioservices, Inc. Transaction History

Peregrine Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$9.4 - $14.04 $220,693 - $329,631	-23,478 Reduced 5.75%	384,608 $3.63 Million
Q2 2023 Jul 26, 2023	SELL	$12.96 - $20.93 $1,814 - $2,930	-140 Reduced 0.03%	408,086 $5.7 Million
Q1 2023 Apr 26, 2023	BUY	$13.48 - $18.79 $156,664 - $218,377	11,622 Added 2.93%	408,226 $7.66 Million
Q4 2022 Jan 10, 2023	SELL	$12.61 - $18.74 $147,108 - $218,620	-11,666 Reduced 2.86%	396,604 $5.46 Million
Q3 2022 Oct 26, 2022	SELL	$15.33 - $20.36 $345,737 - $459,179	-22,553 Reduced 5.23%	408,270 $7.81 Million
Q2 2022 Jul 20, 2022	BUY	$11.63 - $21.55 $860 - $1,594	74 Added 0.02%	430,823 $6.57 Million
Q1 2022 Apr 27, 2022	SELL	$16.63 - $27.73 $526,289 - $877,571	-31,647 Reduced 6.84%	430,749 $8.77 Million
Q4 2021 Jan 31, 2022	BUY	$20.7 - $34.18 $267,754 - $442,118	12,935 Added 2.88%	462,396 $13.5 Million
Q3 2021 Nov 02, 2021	BUY	$19.05 - $28.32 $2.26 Million - $3.35 Million	118,463 Added 35.79%	449,461 $9.7 Million
Q2 2021 Aug 03, 2021	BUY	$18.93 - $25.65 $6.27 Million - $8.49 Million	330,998 New	330,998 $8.49 Million

187

69.3M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $772M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.